PET/MRI Artificial Intelligence Reconstruction Algorithm AIR Recon DL Image Quality Evaluation and Clinical Study
NCT06856096 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65
Last updated 2025-03-04
Summary
PET/MRI artificial intelligence reconstruction algorithm AIR Recon DL image quality evaluation and clinical study
Conditions
- Parkinson's Syndrome
Interventions
- DIAGNOSTIC_TEST
-
PET/MRI
PET/MR imaging using an integrated TOF PET/MR scanner (Signa, GE Healthcare, WI, USA)
Sponsors & Collaborators
-
Xijing Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-02-10
- Primary Completion
- 2027-01-15
- Completion
- 2027-01-15
Countries
- China
Study Locations
More Related Trials
-
Evaluation of a Multimodal Neuroimaging Method for Diagnosis in Parkinsonian Syndromes
NCT02428816 ·Status: COMPLETED ·Phase: NA
-
Non-invasive Diagnosis of Parkinson's Disease
NCT07201610 ·Status: NOT_YET_RECRUITING
-
PET Imaging in Parkinson Disease Dementia
NCT01052350 ·Status: ACTIVE_NOT_RECRUITING
-
The National Registry Study For the Real-world Patients With Parkinsonian Disorders in China
NCT03649503 ·Status: RECRUITING
-
Unravelling the Alteration of Brain Structure and Function in Parkinson´s Disease With Ultra-high Field MRI
NCT03866044 ·Status: UNKNOWN
-
PET Imaging Study of Neurochemical and Autonomic Disorders in Multiple System Atrophy (MSA)
NCT02035761 ·Status: COMPLETED
-
Longitudinal Study of Mild Cognitive Impairment in Parkinson's Disease
NCT02637089 ·Status: UNKNOWN
-
The Novel 18F-labeled MAO-B PET Tracer Study in Parkinsonism Patients
NCT06010290 ·Status: UNKNOWN
-
Investigating the Microstructural and Functional Alterations of Brain in Parkinson's Disease Patients
NCT02599753 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Motor Imagery and Action Observation on Upper Limb Motor Chances and Cognitive Chances in Parkinson's Disease
NCT05696925 ·Status: COMPLETED ·Phase: NA
-
Development of a Novel 18F-DTBZ PET Imaging as a Biomarker to Monitor Neurodegeneration of PARK6 and PARK8 Parkinsonism
NCT01759888 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study to Evaluate the Severity of Motor Dysfunction in Parkinson's Disease Based on AI Video Analysis
NCT03655171 ·Status: COMPLETED
-
Long-term Longitudinal Imaging of Presynaptic Terminals in PD
NCT06875765 ·Status: RECRUITING ·Phase: NA
-
Imaging in the Diagnosis of Parkinson's Disease and Essential Tremor
NCT01446939 ·Status: UNKNOWN
-
AI-Enhanced Optimization of Acute Levodopa Challenge Test
NCT06949865 ·Status: RECRUITING
-
Imaging Biomarkers of Progression of Mobility Impairment in Parkinson Disease
NCT01106976 ·Status: COMPLETED
-
Rehabilitation of Everyday Memory Impairment in Parkinson Disease: A Pilot Study
NCT01469741 ·Status: COMPLETED ·Phase: NA
-
NMR Based Metabolomic Study of Serum Biomarkers in Patients With Parkinson's Disease and Atypical Parkinsonian Syndrome
NCT06490926 ·Status: RECRUITING
-
Imaging Studies of Cognitive Impairment in Parkinson s Disease
NCT01862744 ·Status: COMPLETED
-
Parkinson Disease Before and After Medication and Rehabilitation Treatment
NCT02672943 ·Status: UNKNOWN ·Phase: NA
-
Dementia Registry for Parkinson's Disease
NCT01251094 ·Status: COMPLETED
-
Early Biomarkers of Neurodegeneration in Parkinsonian Syndromes
NCT06155942 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
[18F] - FD17 PET Imaging of α-synuclein: A Clinical Study in α-synucleinopathy Patients
NCT06738862 ·Status: COMPLETED
-
Neuroimaging Studies of Depression in Parkinson's Disease
NCT00518258 ·Status: COMPLETED
-
Patient-Specific 3D Action Observation Training in Parkinson's Disease
NCT07250672 ·Status: RECRUITING ·Phase: NA